Results 11 to 20 of about 21,823 (236)

Association between duration of dysphagia and dysphonia with insomnia: results from the National Health Interview Survey [PDF]

Frontiers in Neurology
BackgroundInsomnia markedly impairs health and quality of life. This study used the 2022 National Health Interview Survey (NHIS) data to explore the relationships among dysphagia duration, dysphonia duration, and insomnia.MethodsWith the 2022 NHIS data ...
Kai Zhou, Wen Zhao, Jiehua Gan, Guomin Xie, Xiping Wu, Zhongyue Lv   +5 more
doaj   +2 more sources

Intelligent Automation Improved Efficiency in Pharmacovigilance Safety Signal Assessment. [PDF]

Clin Pharmacol Ther
Pharmacovigilance is the science involving the detection, assessment, understanding, and prevention of adverse events associated with drugs, biologics, or medical devices. In pharmacovigilance, information that suggests a new potential causal relationship between an intervention and an adverse event is called a safety signal. Following their detection,
Warner J, Teodoro LHS, Jardim AP, Albera C.   +3 more
europepmc   +2 more sources

Vibratory Characteristics and Quantitative Parameters of Laryngeal Dystonia: A Scoping Review of High-Speed Videoendoscopy Studies. [PDF]

World J Otorhinolaryngol Head Neck Surg
ABSTRACT Objective To review the clinical application and quantitative parameters of high‐speed videoendoscopy (HSV) in evaluating vocal fold kinematics in patients with laryngeal dystonia (LD), to summarize the limitations of existing studies, and to provide a reference for future clinical standardization.
Hu YJ, Song J, Zheng SN, Xing L, Feng YJ, Wu ST, Zeng SY, Tan YS, Chen QT, Zhuang PY.   +9 more
europepmc   +2 more sources

National Trends in Utilization of Speech‐Language Pathology and Otolaryngology Services for Dysphonia [PDF]

Laryngoscope Investigative Otolaryngology
Objective Dysphonia affects a growing number of individuals in the United States, but many do not receive targeted care. This study explores trends in speech‐language pathology (SLP) and otolaryngology utilization in a large, national cohort of ...
Vicki Liu, Kyle Cook, Dori Smith, Helena Yip   +3 more
doaj   +2 more sources

Dysphonia after Bevacizumab Rechallenge: A Case Report

Case Reports in Oncology, 2015
Inhibition of vascular endothelial growth factor (VEGF) signaling, an initiator of tumor angiogenesis, inhibits tumor growth and invasion. Bevacizumab, a monoclonal antibody to VEGF, in common use as an adjunct to standard chemotherapy like irinotecan in
Corey A. Carter, Scott Z. Caroen, Arnold L. Oronsky, Bryan T. Oronsky   +3 more
doaj   +2 more sources

Peri- and Post-Menopausal Hormone Replacement Therapy and Voice Disorder Risk: A TriNetX Study. [PDF]

Laryngoscope
ABSTRACT Objectives The aim of this study was to elucidate the risk of developing voice disorders among peri‐ and post‐menopausal female hormone replacement therapy (HRT) users. Methods A retrospective cohort study was conducted using the TriNetX Global Collaborative Network.
Kayekjian D, Chun WB, Nguyen SA, O'Rourke AK, Meenan KD.   +4 more
europepmc   +2 more sources

Dysphonia in Occupational Voice Users: Risk Factors, Causes and Socioepidemiological Profiles [PDF]

Medicina
Background and Objectives: Professional voice users (PVUs) are individuals for whom the voice is the primary tool of work, and whose professional success and income largely depend on its quality.
Jasmina Stojanovic, Snezana Radovanovic, Milica Jevtic, Strahinja Krsmanovic, Marina Jovanovic, Andra Jevtovic, Snezana Babac, Mila Veselinovic, Mila Bojanovic, Sanja B. Krejovic-Trivic, Jovana Pficer Kuzmanovic, Maja Vulovic, Milos Stepovic, Nenad Relic   +13 more
doaj   +2 more sources

Long-Term Outcomes of Patients Undergoing Cricothyrotomy at a Tertiary Care Level One Trauma Center. [PDF]

Laryngoscope
This retrospective study of 48 patients undergoing emergent cricothyrotomy (2014–2025) evaluated short‐ and long‐term outcomes and complications. Common complications included dysphagia, pneumonia, and dysphonia, with delayed conversion to tracheostomy associated with increased pneumonia risk; long‐term issues included persistent dysphagia, subglottic ...
Raizada S, Shapiro Y, Modi R, Balouch B, Zhang K, Chovanes J, Solomon D.   +6 more
europepmc   +2 more sources

Seronegative Granulomatous Myositis With Bulbar Weakness and Reversible Cardiomyopathy: A Case Report. [PDF]

Clin Case Rep
ABSTRACT A 64‐year‐old woman presented with seronegative idiopathic granulomatous myositis, featuring severe bulbar weakness, reversible cardiomyopathy (ejection fraction 20%–25%), hepatic injury, and acute kidney injury. Muscle biopsy confirmed granulomatous inflammation.
Vaidyanathan BR, Abubacker M, Ponugupati J.   +2 more
europepmc   +2 more sources

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

Hepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou   +13 more
wiley   +1 more source